CD4 and neoplasm: Furthermore, HGGs are known to be resistant to immune checkpoint blockade therapy, partly due to a subpopulation of CD4 + T cells that express CXCL8 and contribute to tumor growth and reduced efficacy of immune checkpoint inhibitors.